BioSpace News Archive

The expansion includes antibodies to infectious disease, inflammation, cardiac, hormone, immunoglobulins and assay control targets.

With experience of different commercial systems, Dr Rousso talks about why the JPK system offers particularly helpful capabilities.

Lightning-Link is an innovative technology that enables direct labeling of antibodies or proteins in as little as 20 minutes, for use in R&D applications, drug discovery and the development of diagnostic kits.

Oncoceutics and Frontida BioPharm announced that the two companies have entered into a product development and commercialization agreement to further develop and scale-up the finished product manufacturing process for ONC201,

Novoheart announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for a three-tiered drug screening system with enhanced capability, sensitivity and accuracy for detecting pharmacological effects on heart contractility that cannot be achieved with conventional models.

The Millar catheter provides an easier way to measure pressures in these patients due to its reduced size and signal accuracy.

GigaGen will use the funds to develop a natural repertoire antibody protein expression system.

PDI announces the appointment of Tom McCurdy as Senior VP and General Manager for its healthcare division and promotes Esperanza Carrion to VP and General Manager of Sani Professional.

Siemens Healthineers today laid out its strategy to bolster its market leadership by 2025 and beyond.

Ampio today reported a heavy schedule of meetings throughout the four-day conference, predominately with significant pharma companies discussing the successful clinical results of the company’s second pivotal phase III trial announced Dec. 14, 2017.